218 related articles for article (PubMed ID: 15146603)
1. [Molecular mechanisms of bile formation and cholestatic diseases].
Poupon R
Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
[TBL] [Abstract][Full Text] [Related]
2. [Cholestasis and cholestatic liver diseases].
Poupon R
Gastroenterol Clin Biol; 2009; 33(8-9):778-88. PubMed ID: 19556086
[TBL] [Abstract][Full Text] [Related]
3. [Biliary function and its regulation].
Poupon R; Chignard N; Rosmorduc O; Barbu V; Housset C
Med Sci (Paris); 2004 Dec; 20(12):1096-9. PubMed ID: 15581462
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of cholestatic liver diseases.
Paumgartner G
J Dig Dis; 2010 Jun; 11(3):119-25. PubMed ID: 20579215
[TBL] [Abstract][Full Text] [Related]
5. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
Beuers U
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of cholestatic liver disease and therapeutic approaches.
Hirschfield GM; Heathcote EJ; Gershwin ME
Gastroenterology; 2010 Nov; 139(5):1481-96. PubMed ID: 20849855
[TBL] [Abstract][Full Text] [Related]
8. [Cholestatic liver diseases].
Reichel C; Meier-Abt PJ
Ther Umsch; 1997 Nov; 54(11):639-44. PubMed ID: 9454366
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.
Roma MG; Crocenzi FA; Sánchez Pozzi EA
Clin Sci (Lond); 2008 May; 114(9):567-88. PubMed ID: 18377365
[TBL] [Abstract][Full Text] [Related]
10. [Cholestatic liver disease in children].
Jankowska I; Pawłowska J; Swiatkowska E; Rujner J; Socha J
Przegl Epidemiol; 2002; 56 Suppl 5():16-21. PubMed ID: 15553067
[TBL] [Abstract][Full Text] [Related]
11. New therapeutical indications of ursodeoxycholic acid.
Copaci I; Micu L; Iliescu L; Voiculescu M
Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
[TBL] [Abstract][Full Text] [Related]
12. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
Marschall HU; Wagner M; Zollner G; Fickert P; Diczfalusy U; Gumhold J; Silbert D; Fuchsbichler A; Benthin L; Grundström R; Gustafsson U; Sahlin S; Einarsson C; Trauner M
Gastroenterology; 2005 Aug; 129(2):476-85. PubMed ID: 16083704
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors, bile acids and cholesterol homeostasis series - bile acids and pregnancy.
Abu-Hayyeh S; Papacleovoulou G; Williamson C
Mol Cell Endocrinol; 2013 Apr; 368(1-2):120-8. PubMed ID: 23159988
[TBL] [Abstract][Full Text] [Related]
14. Biliary physiology and disease: reflections of a physician-scientist.
Paumgartner G
Hepatology; 2010 Apr; 51(4):1095-106. PubMed ID: 20373364
[TBL] [Abstract][Full Text] [Related]
15. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
16. Bile salts and cholestasis.
Maillette de Buy Wenniger L; Beuers U
Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
[TBL] [Abstract][Full Text] [Related]
17. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases.
Oude Elferink RP; Paulusma CC; Groen AK
Gastroenterology; 2006 Mar; 130(3):908-25. PubMed ID: 16530529
[TBL] [Abstract][Full Text] [Related]
18. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
Zollner G; Marschall HU; Wagner M; Trauner M
Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
[TBL] [Abstract][Full Text] [Related]
19. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
Arenas F; Hervias I; Uriz M; Joplin R; Prieto J; Medina JF
J Clin Invest; 2008 Feb; 118(2):695-709. PubMed ID: 18188457
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of cholestasis.
Zollner G; Trauner M
Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
